T2 Biosystems 获得 FDA 510(k) 批准，扩大 T2Bacteria Panel，包括检测鲍曼不动杆菌的血流感染。 T2 Biosystems receives FDA 510(k) clearance for an expanded T2Bacteria Panel, including detection of Acinetobacter baumannii for bloodstream infections.

T2 Biosystems 最近获得了 FDA 510(k) 许可，扩大了其 T2Bacteria Panel 的范围，以允许检测鲍曼不动杆菌，这是一种引起血液感染的细菌，特别是在危重患者中。 T2 Biosystems recently acquired FDA 510(k) clearance, expanding its T2Bacteria Panel to allow for the detection of Acinetobacter baumannii, a bacterial species causing bloodstream infections, particularly in critically ill patients. 新的 panel 包括六种引起败血症的病原体的检测，提高了 T2Bacteria Panel 检测引起败血症的病原体的效率。 The new panel includes the detection of six sepsis-causing pathogens, enhancing the T2Bacteria Panel's efficiency for detecting sepsis-causing pathogens.